Trade name of the drug: Phezam^®

International nonproprietary or generic name: piracetam + cinnarizine

Dosage form: capsules

Composition 1 capsule contains:

active ingredients – piracetam 400.0 mg, cinnarizine 25.0 mg;

excipients – lactose monohydrate 55.0 mg, colloidal silicon dioxide 15.0 mg, magnesium stearate 5.0 mg. The capsule shell contains titanium dioxide 2%, gelatin 98%.

Description

Hard, cylindrical gelatin capsules, white, No. 0.

Powdery mixture, from white to almost white in color, the presence of conglomerates is allowed, which, when pressed with a glass rod, easily turns into powder.

Pharmacotherapeutic group: Nootropic agent

Pharmacological action

Pharmacodynamics

Combined medicinal drug

• Piracetam: 400.0 mg (active substance)
• Cinnarizine: 25.0 mg (active substance)
• Lactose monohydrate: 55.0 mg (excipient)
• Colloidal silicon dioxide: 15.0 mg (excipient)
• Magnesium stearate: 5.0 mg (excipient)
• Capsule shell: gelatin 98%, titanium dioxide 2%

Fezam is typically taken orally, 1–2 capsules two to three times daily, preferably with meals. The course of treatment usually lasts 1–3 months and should be determined by a physician. Capsules should be swallowed whole with a sufficient amount of water. Do not adjust the dose or duration of treatment without consulting your doctor.

fawsfgsag